Search Results - "Hernández Rivas, J.A"
-
1
Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale
Published in Journal of geriatric oncology (01-09-2015)“…Abstract Objectives The purpose of this study was to develop a new brief, comprehensive geriatric assessment scale for older patients diagnosed with different…”
Get full text
Journal Article -
2
PF357 A NOVEL REFINED PROGNOSTIC MODEL FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS COMBINING IGH TRANSLOCATIONS AND NEXT‐GENERATION SEQUENCING
Published in HemaSphere (01-06-2019)“…Background: Chromosome 14q32 translocations involving the immunoglobulin heavy chain gene (IGH) are uncommon in chronic lymphocytic leukemia (CLL) patients…”
Get full text
Journal Article -
3
Sintra-Rev Clinical Trial: Preliminary Analysis of Efficacy and Safety at Week 12 of Treatment in MDS Del(5Q) and Transfusion Independence
Published in Leukemia research (01-04-2017)Get full text
Journal Article -
4
Incidence of Thromboembolic Events in Cancer Hospitalized Patients With COVID-19
Published in Chest (01-06-2021)Get full text
Journal Article -
5
-
6
-
7
PB1826 COMPOSITE LYMPHOMA CONTAINING MANTLE CELL AND PERIPHERAL T‐CELL LYMPHOMA, NOT OTHERWISE SPECIFIED: A REPORT OF 2 CASES TREATED WITH UP‐FRONT AUTOLOGOUS STEM CELL TRANSPLANTATION
Published in HemaSphere (01-06-2019)“…Background: Composite lymphomas are a rare entity defined by the presence of two different lymphomas in the same patient and in the same organ. Aims: To…”
Get full text
Journal Article -
8
168 Impact of comorbidities in patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) treated with azacitidine (AZA)
Published in Leukemia research (01-05-2011)Get full text
Journal Article -
9
81 - Sintra-Rev Clinical Trial: Preliminary Analysis of Efficacy and Safety at Week 12 of Treatment in MDS Del(5Q) and Transfusion Independence
Published in Leukemia research (01-04-2017)Get full text
Journal Article -
10
-
11
Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: LONG-TERM MUTATIONAL DYNAMICS IN DEL(5Q) MDS PATIENTS EARLY TREATED WTIH LENALIDOMIDE (SINTRAREV CLINICAL TRIAL). SAFE AND EFFECITIVE APPROACH REGARDING CLONAL EVOLUTION?
Published in Leukemia research (01-05-2023)Get full text
Journal Article -
12
Clinical Efficacy of Bortezomib Based Therapy in Plasma Cell Leukemias
Published in Blood (16-11-2007)“…Introduction Plasma Cell Leukemia (PCL) is characterized by a high number of plasma cells in peripheral blood (>2 × 109/L) and more than 20% of circulating…”
Get full text
Journal Article -
13
Niño de 3 meses con anemia hemolítica no autoinmune
Published in Anales de pediatría (Barcelona, Spain : 2003) (2001)Get full text
Journal Article